Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Vitreoretinal medical procedures are embraced to treat eye issue identified with the retina, macula, and vitreous liquid. Vitreoretinal medical procedure techniques normally incorporate retinal tears, diabetic retinopathy, retinal separations, visual injury, macular degeneration, visual tumor treatment and inherited retinal sickness treatment. The assortment of instruments, devices, and careful hardware intended to enable specialists to execute the medical procedure fall under the umbrella of medical devices called vitreoretinal surgery devices.
The tremendous and rapid rise in the worldwide populace of geriatrics, a demographic considered most vulnerable against vitreoretinal issue, for example, macular degeneration, is one of the key variables to have driven a huge ascent in the quantity of vitreoretinal medical procedures occurring globally. Further, In the course of recent years, the worldwide market for vitreoretinal surgery device has seen huge progressions as far as the easy availability of specialized solutions, and instruments, which take into consideration less invasive procedures, diminish the measure of amount of suffering to the eye, and lead to decreased reduced healing time and enhanced patient results. In addition, advancements in the market keep on occurring at a quick pace and increasing number of companies are manufacturing highly sophisticated vitreoretinal surgery devices capable of supporting the surgery technique and the overall efficiency of the of the methodology . Furthermore, rising awareness about eye care has further contributed to number of vitreoretinal surgeries performed worldwide.
The global vitreoretinal surgery devices is segmented based on type, end user and region.
Vitrectomy surgery devices, Photocoagulation surgery devices and Illumination surgery devices are the major types of vitreoretinal surgery devices. Vitrectomy is a surgical procedure employed to remove vitreous gel from the eye. It is carried out when there is retinal detachment with vitreous hemorrhage. In addition, it is for various repairs such as removal of scar tissue and treatment for small holes or tear in the macula. The progress of the global vitrectomy devices market is driven by increase in percentage of geriatric population and technological advancements in surgical equipment.
By end user, the market is categorised into hospitals, ophthalmology clinics and ambulatory surgical centres.
Geographically, the global vitreoretinal surgery devices market is segmented North America, Asia Pacific, Europe and Rest of the World.North America is currently the leading contributor to the revenue of the global vitreoretinal surgery market, chiefly owing to the highly developed healthcare infrastructure, vast population base of geriatrics, and an encouraging medical reimbursement structure.
The Asia Pacific region is expect to show the lucrative growth owing to the increased number in diabetic patients suffering from diabetic retinopathy. The increasing healthcare expenditure in China and India and high geriatric population in this region is the primary driver for the growth of the market.
Some of the major players operating in the global vitreoretinal surgery market are Dutch Ophthalmic Research Center International BV, Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, Designs For Vision Pty Ltd, MedOne Surgical, Inc., and Alcon, Inc. among others
